KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Shares Outstanding (Diluted Average) (2016 - 2025)

LifeMD's Shares Outstanding (Diluted Average) history spans 12 years, with the latest figure at $45.1 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 9.55% year-over-year to $45.1 million; the TTM value through Dec 2025 reached $45.1 million, up 9.55%, while the annual FY2025 figure was $45.1 million, 9.55% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $45.1 million in Q4 2025 per LFMD's latest filing, up from $44.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $45.6 million in Q1 2025 to a low of $24.5 million in Q1 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $35.0 million, with a median of $33.2 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): skyrocketed 128.72% in 2021, then increased 2.68% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $27.0 million in 2021, then increased by 14.69% to $31.0 million in 2022, then rose by 9.45% to $33.9 million in 2023, then grew by 21.5% to $41.2 million in 2024, then rose by 9.55% to $45.1 million in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Shares Outstanding (Diluted Average) are $45.1 million (Q4 2025), $44.6 million (Q3 2025), and $44.4 million (Q2 2025).